메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

EID: 84862173145     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-155     Document Type: Article
Times cited : (19)

References (38)
  • 1
    • 0028028308 scopus 로고
    • Angiogenesis inhibition: a review. [Review] [436 refs]
    • 10.1016/0163-7258(94)90027-2, 7530374
    • Auerbach W, Auerbach R. Angiogenesis inhibition: a review. [Review] [436 refs]. Pharmacol Ther 1994, 63:265-311. 10.1016/0163-7258(94)90027-2, 7530374.
    • (1994) Pharmacol Ther , vol.63 , pp. 265-311
    • Auerbach, W.1    Auerbach, R.2
  • 2
    • 0038687221 scopus 로고    scopus 로고
    • Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. [Review] [122 refs]
    • 10.1016/S0361-090X(03)00030-8, 3384426, 22745585
    • Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F, Albini A. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. [Review] [122 refs]. Cancer Detection & Prevention 2003, 27:229-238. 10.1016/S0361-090X(03)00030-8, 3384426, 22745585.
    • (2003) Cancer Detection & Prevention , vol.27 , pp. 229-238
    • Bisacchi, D.1    Benelli, R.2    Vanzetto, C.3    Ferrari, N.4    Tosetti, F.5    Albini, A.6
  • 3
    • 0642377237 scopus 로고    scopus 로고
    • Antiangiogenesis: the fifth cancer treatment modality?. [Review] [61 refs]
    • 10.1188/03.ONF.934-944, 14603351
    • Camp-Sorrell D. Antiangiogenesis: the fifth cancer treatment modality?. [Review] [61 refs]. Oncology Nursing Forum 2003, 30:934-944. 10.1188/03.ONF.934-944, 14603351.
    • (2003) Oncology Nursing Forum , vol.30 , pp. 934-944
    • Camp-Sorrell, D.1
  • 5
    • 33644948640 scopus 로고    scopus 로고
    • Antiangiogenesis: a possible treatment option for prostate cancer?. [Review] [86 refs]
    • 10.3816/CGC.2005.n.033, 16425989
    • Longoria RL, Cox MC, Figg WD. Antiangiogenesis: a possible treatment option for prostate cancer?. [Review] [86 refs]. Clinical Genitourinary Cancer 2005, 4:197-202. 10.3816/CGC.2005.n.033, 16425989.
    • (2005) Clinical Genitourinary Cancer , vol.4 , pp. 197-202
    • Longoria, R.L.1    Cox, M.C.2    Figg, W.D.3
  • 6
    • 0032240869 scopus 로고    scopus 로고
    • Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy. [Review] [81 refs]
    • 10.1007/978-3-642-45769-2_33, 9928571
    • Harris AL. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy. [Review] [81 refs]. Recent Results in Cancer Research 1998, 152:341-352. 10.1007/978-3-642-45769-2_33, 9928571.
    • (1998) Recent Results in Cancer Research , vol.152 , pp. 341-352
    • Harris, A.L.1
  • 8
    • 79953330322 scopus 로고    scopus 로고
    • Antiangiogenesis enhances intratumoral drug retention
    • Ma J, Chen CS, Blute T, Waxman DJ. Antiangiogenesis enhances intratumoral drug retention. Cancer Res 71:2675-2685.
    • Cancer Res , vol.71 , pp. 2675-2685
    • Ma, J.1    Chen, C.S.2    Blute, T.3    Waxman, D.J.4
  • 9
    • 39049165334 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth
    • 10.1158/0008-5472.CAN-07-3217, 18199548
    • Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res 2008, 68:521-529. 10.1158/0008-5472.CAN-07-3217, 18199548.
    • (2008) Cancer Res , vol.68 , pp. 521-529
    • Ebos, J.M.1    Lee, C.R.2    Bogdanovic, E.3    Alami, J.4    Van Slyke, P.5    Francia, G.6    Xu, P.7    Mutsaers, A.J.8    Dumont, D.J.9    Kerbel, R.S.10
  • 10
    • 0036054742 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. [Review] [97 refs]
    • Conti CJ. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. [Review] [97 refs]. Oncologist 2002, 3:4-11.
    • (2002) Oncologist , vol.3 , pp. 4-11
    • Conti, C.J.1
  • 11
    • 35448952213 scopus 로고    scopus 로고
    • Antiangiogenic agents: an update on small molecule VEGFR inhibitors. [Review] [194 refs]
    • 2495
    • Schenone S, Bondavalli F, Botta M. Antiangiogenic agents: an update on small molecule VEGFR inhibitors. [Review] [194 refs]. Curr Med Chem 14:2495-2516. 2495.
    • Curr Med Chem , vol.14 , pp. 2495-2516
    • Schenone, S.1    Bondavalli, F.2    Botta, M.3
  • 12
    • 33144459287 scopus 로고    scopus 로고
    • VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. [Review] [80 refs]
    • 1360224, 16146773
    • Rahimi N. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. [Review] [80 refs]. Front Biosci 2006, 11:818-829. 1360224, 16146773.
    • (2006) Front Biosci , vol.11 , pp. 818-829
    • Rahimi, N.1
  • 13
    • 34547152236 scopus 로고    scopus 로고
    • Antiangiogenesis, anti-VEGF(R) and outlook. [Review] [38 refs]
    • 10.1007/978-3-540-46091-6_16, 17607926
    • Petersen I. Antiangiogenesis, anti-VEGF(R) and outlook. [Review] [38 refs]. Recent Results in Cancer Research 2007, 176:189-199. 10.1007/978-3-540-46091-6_16, 17607926.
    • (2007) Recent Results in Cancer Research , vol.176 , pp. 189-199
    • Petersen, I.1
  • 14
    • 34548443831 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. [Review] [112 refs]
    • Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. [Review] [112 refs]. Cell Signal 2003, 19:2003-2012.
    • (2003) Cell Signal , vol.19 , pp. 2003-2012
    • Holmes, K.1    Roberts, O.L.2    Thomas, A.M.3    Cross, M.J.4
  • 17
    • 67650337790 scopus 로고    scopus 로고
    • Development of bacterial vectors for tumor-targeted gene therapy. [Review] [108 refs]
    • 10.1007/978-1-59745-561-9_7, 19565900
    • Jia LJ, Hua ZC. Development of bacterial vectors for tumor-targeted gene therapy. [Review] [108 refs]. Methods in Molecular Biology 2009, 542:131-154. 10.1007/978-1-59745-561-9_7, 19565900.
    • (2009) Methods in Molecular Biology , vol.542 , pp. 131-154
    • Jia, L.J.1    Hua, Z.C.2
  • 20
    • 33646671508 scopus 로고    scopus 로고
    • Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. [Review] [23 refs]
    • 10.2325/jbcs.13.27, 16518059
    • Fujimori M. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. [Review] [23 refs]. Breast Cancer 2006, 13:27-31. 10.2325/jbcs.13.27, 16518059.
    • (2006) Breast Cancer , vol.13 , pp. 27-31
    • Fujimori, M.1
  • 21
    • 79956364212 scopus 로고    scopus 로고
    • Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion
    • 10.1136/bjo.2010.192468, 21109696
    • Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K. Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Br J Ophthalmol 2011, 95:788-792. 10.1136/bjo.2010.192468, 21109696.
    • (2011) Br J Ophthalmol , vol.95 , pp. 788-792
    • Noma, H.1    Funatsu, H.2    Mimura, T.3    Eguchi, S.4    Shimada, K.5
  • 22
    • 18844382645 scopus 로고    scopus 로고
    • Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma
    • 10.1111/j.1745-7254.2005.00094.x, 15842785
    • Yi C, Huang Y, Guo ZY, Wang SR. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 2005, 26:629-634. 10.1111/j.1745-7254.2005.00094.x, 15842785.
    • (2005) Acta Pharmacol Sin , vol.26 , pp. 629-634
    • Yi, C.1    Huang, Y.2    Guo, Z.Y.3    Wang, S.R.4
  • 24
    • 66049084202 scopus 로고    scopus 로고
    • MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
    • November
    • Bo L, Xiao-Chun P, Zheng X-L. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer November 2009, 66(2):169-175.
    • (2009) Lung Cancer , vol.66 , Issue.2 , pp. 169-175
    • Bo, L.1    Xiao-Chun, P.2    Zheng, X.-L.3
  • 25
    • 1242314730 scopus 로고    scopus 로고
    • Precision of the fractionator from Cavalieri designs
    • 10.1111/j.1365-2818.2004.01291.x, 14731303
    • Cruz-Orive LM. Precision of the fractionator from Cavalieri designs. J Microsc 2004, 213:205-211. 10.1111/j.1365-2818.2004.01291.x, 14731303.
    • (2004) J Microsc , vol.213 , pp. 205-211
    • Cruz-Orive, L.M.1
  • 26
    • 0025120720 scopus 로고
    • Doppler ultrasound color flow imaging in the study of breast cancer; Preliminary findings
    • 10.1016/0301-5629(90)90020-D, 2238263
    • Adler DD, Carson PL, Rubin JM, Q-R D. Doppler ultrasound color flow imaging in the study of breast cancer; Preliminary findings. Ultrasound Med Biol 1990, 16:553-559. 10.1016/0301-5629(90)90020-D, 2238263.
    • (1990) Ultrasound Med Biol , vol.16 , pp. 553-559
    • Adler, D.D.1    Carson, P.L.2    Rubin, J.M.3    Q-R, D.4
  • 27
    • 68249155377 scopus 로고    scopus 로고
    • Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice
    • Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, Ji LL, Song HB, Yi C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. Bmc Cancer 2009, 9.
    • (2009) Bmc Cancer , vol.9
    • Liu, T.G.1    Huang, Y.2    Cui, D.D.3    Huang, X.B.4    Mao, S.H.5    Ji, L.L.6    Song, H.B.7    Yi, C.8
  • 28
    • 14044267657 scopus 로고    scopus 로고
    • Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas
    • 10.1007/s11060-004-9163-5, 15719267
    • Wang M, Tang J, Liu S, Yoshida D, Teramoto A. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas. J Neurooncol 2005, 71:3-7. 10.1007/s11060-004-9163-5, 15719267.
    • (2005) J Neurooncol , vol.71 , pp. 3-7
    • Wang, M.1    Tang, J.2    Liu, S.3    Yoshida, D.4    Teramoto, A.5
  • 29
    • 0032542528 scopus 로고    scopus 로고
    • Gene therapy strategies for tumor antiangiogenesis. [Review] [224 refs]
    • 10.1093/jnci/90.4.273, 9486813
    • Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis. [Review] [224 refs]. Journal of the National Cancer Institute 1998, 90:273-286. 10.1093/jnci/90.4.273, 9486813.
    • (1998) Journal of the National Cancer Institute , vol.90 , pp. 273-286
    • Kong, H.L.1    Crystal, R.G.2
  • 30
    • 67651120191 scopus 로고    scopus 로고
    • Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth
    • 10.1038/cgt.2009.7, 19229287
    • Hu B, Kou L, Li C, Zhu LP, Fan YR, Wu ZW, Wang JJ, Xu GX. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Therapy 2009, 16:655-663. 10.1038/cgt.2009.7, 19229287.
    • (2009) Cancer Gene Therapy , vol.16 , pp. 655-663
    • Hu, B.1    Kou, L.2    Li, C.3    Zhu, L.P.4    Fan, Y.R.5    Wu, Z.W.6    Wang, J.J.7    Xu, G.X.8
  • 31
    • 15444379976 scopus 로고    scopus 로고
    • Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas
    • 10.1038/sj.gt.3302432, 15616600
    • Kaliberov SA, Kaliberova LN, Buchsbaum DJ. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. Gene Therapy 2005, 12:407-417. 10.1038/sj.gt.3302432, 15616600.
    • (2005) Gene Therapy , vol.12 , pp. 407-417
    • Kaliberov, S.A.1    Kaliberova, L.N.2    Buchsbaum, D.J.3
  • 32
    • 33749103965 scopus 로고    scopus 로고
    • Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors
    • 10.1023/A:1010644217648, 3383288, 22745540
    • Yazawa K, Fujimori M, Nakamura T, Sasaki T, Amano J, Kano Y, Taniguchi S. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Research & Treatment 2001, 66:165-170. 10.1023/A:1010644217648, 3383288, 22745540.
    • (2001) Breast Cancer Research & Treatment , vol.66 , pp. 165-170
    • Yazawa, K.1    Fujimori, M.2    Nakamura, T.3    Sasaki, T.4    Amano, J.5    Kano, Y.6    Taniguchi, S.7
  • 33
    • 0018888153 scopus 로고    scopus 로고
    • Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration
    • Kimura NT, Taniguchi S, Aoki K, Baba T. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res 2061, 40:2061-2068.
    • (2061) Cancer Res , vol.40 , pp. 2061-2068
    • Kimura, N.T.1    Taniguchi, S.2    Aoki, K.3    Baba, T.4
  • 34
    • 0034032620 scopus 로고    scopus 로고
    • Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors
    • 10.1038/sj.cgt.7700122, 10770636
    • Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi S. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Therapy 2000, 7:269-274. 10.1038/sj.cgt.7700122, 10770636.
    • (2000) Cancer Gene Therapy , vol.7 , pp. 269-274
    • Yazawa, K.1    Fujimori, M.2    Amano, J.3    Kano, Y.4    Taniguchi, S.5
  • 35
    • 0026149395 scopus 로고
    • Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve
    • 10.3168/jds.S0022-0302(91)78272-6, 1860970
    • Yasui H, MO. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 1991, 74:1187-1195. 10.3168/jds.S0022-0302(91)78272-6, 1860970.
    • (1991) J Dairy Sci , vol.74 , pp. 1187-1195
    • Yasui, H.1    Ohwaki, M.2
  • 36
    • 0034032620 scopus 로고    scopus 로고
    • Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors
    • 10.1038/sj.cgt.7700122, 10770636
    • Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi S. Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors. Cancer Gene Ther 2000, 7:269-274. 10.1038/sj.cgt.7700122, 10770636.
    • (2000) Cancer Gene Ther , vol.7 , pp. 269-274
    • Yazawa, K.1    Fujimori, M.2    Amano, J.3    Kano, Y.4    Taniguchi, S.5
  • 37
    • 0037328974 scopus 로고    scopus 로고
    • Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth
    • 10.1038/sj.cgt.7700530, 12536198
    • Xi L, Geng-Feng F, Yan-Rong F. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther 2003, 10:105-111. 10.1038/sj.cgt.7700530, 12536198.
    • (2003) Cancer Gene Ther , vol.10 , pp. 105-111
    • Xi, L.1    Geng-Feng, F.2    Yan-Rong, F.3
  • 38
    • 0031867648 scopus 로고    scopus 로고
    • Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2
    • 10.1006/excr.1998.4039, 9633524
    • Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, Weich HA. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 1998, 241:161-170. 10.1006/excr.1998.4039, 9633524.
    • (1998) Exp Cell Res , vol.241 , pp. 161-170
    • Roeckl, W.1    Hecht, D.2    Sztajer, H.3    Waltenberger, J.4    Yayon, A.5    Weich, H.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.